Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank47
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P47
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-5.23%
Q2 202547.43%
Q1 2025-10.61%
Q4 2024-53.86%
Q3 202429.23%
Q2 202470.87%
Q1 2024-1369.03%
Q4 202313.58%
Q3 2023-6.43%
Q2 20236.02%
Q1 2023-992.30%
Q4 2022-7.02%
Q3 202223.11%
Q2 20228.59%
Q1 2022-66.39%
Q4 2021-147732.17%
Q3 202198.98%
Q2 20210.00%